Spots Global Cancer Trial Database for lymphocytes
Every month we try and update this database with for lymphocytes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. | NCT06334835 | Acute Lymphobla... | lncRNA signatur... | 1 Year - 18 Years | IRCCS SYNLAB SDN | |
| Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT06121557 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Chemotherapeuti... | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma | NCT01404702 | Neuroblastoma | Zoledronic Acid Aldesleukin | 2 Years - 21 Years | University of Alabama at Birmingham | |
| Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia | NCT05093192 | Chronic Lymphoc... Minimal Residua... | Exercise trial | 18 Years - | University of Bath | |
| Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer | NCT06121570 | Breast Neoplasm... | Sentinel Lymph ... Doxorubicin Epirubicin Cyclophosphamid... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Nab-paclitaxel | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia | NCT00077922 | Leukemia Lymphocytic Chronic | LMB-2 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| The Effects of General Anesthetics on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and Mechanism Involved | NCT03193710 | Colorectal Canc... Survival Rate General Anesthe... Lymphocyte Dest... Molecular Mecha... | Propofol Sevoflurane Remifentanil | 18 Years - 65 Years | West China Hospital | |
| Mitochondrial Function of Immune Cells in Sepsis | NCT01600989 | Shock, Septic | blood sampling blood sampling | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients | NCT00512642 | Cancer | 35 Years - 150 Years | National Institutes of Health Clinical Center (CC) | ||
| Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes | NCT00048100 | Leukemia, Myelo... | Apheresis Stem Cell Trans... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma | NCT01659151 | Metastatic Mela... | High Dose Inter... ACT with TIL In... Vemurafenib Lymphodepletion | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia | NCT05093192 | Chronic Lymphoc... Minimal Residua... | Exercise trial | 18 Years - | University of Bath | |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia | NCT00077922 | Leukemia Lymphocytic Chronic | LMB-2 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT06121557 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Chemotherapeuti... | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Mitochondrial Function of Immune Cells in Sepsis | NCT01600989 | Shock, Septic | blood sampling blood sampling | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. | NCT06334835 | Acute Lymphobla... | lncRNA signatur... | 1 Year - 18 Years | IRCCS SYNLAB SDN | |
| Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer | NCT06121570 | Breast Neoplasm... | Sentinel Lymph ... Doxorubicin Epirubicin Cyclophosphamid... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Nab-paclitaxel | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients | NCT00512642 | Cancer | 35 Years - 150 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT05981001 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Nab-paclitaxel Gemcitabine Carboplatin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia | NCT00077922 | Leukemia Lymphocytic Chronic | LMB-2 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT05981001 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Nab-paclitaxel Gemcitabine Carboplatin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT05981001 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Nab-paclitaxel Gemcitabine Carboplatin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors | NCT06047977 | Lymphocytes | Tumor Infiltrat... | 1 Year - 21 Years | Johns Hopkins All Children's Hospital | |
| Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma | NCT03687099 | Glioblastoma | no intervention | 18 Years - | Centre Hospitalier Universitaire, Amiens |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
